Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2010
12/02/2010US20100305121 Novel antagonists of the human fatty acid synthase thioesterase
12/02/2010US20100305100 Methods for treating hepatitis c
12/02/2010US20100305097 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
12/02/2010US20100305093 Inhibitors of mTOR and Methods of Making and Using
12/02/2010US20100305078 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties
12/02/2010US20100305070 Treatment or prophylaxis of proliferative conditions
12/02/2010CA2763700A1 2, 4-diamino pyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
12/02/2010CA2763498A1 Pyrazinylpyrazoles
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010CA2762137A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/01/2010EP2256108A1 Substituted triazine kinase inhibitors
12/01/2010EP2256106A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
12/01/2010EP2254886A2 3,4-dihydro-2h-pyrazinoý1,2-a¨indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/01/2010EP2254878A1 Aldh-2 inhibitors in the treatment of addiction
12/01/2010EP2254862A2 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
12/01/2010EP2254666A1 2-aminoquinolines as 5-ht5a receptor antagonists
12/01/2010EP2254415A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
12/01/2010EP2125792B1 Purine derivatives as immunomodulators
12/01/2010EP1896467B1 Tricyclic opioid modulators
12/01/2010EP1368342B3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/01/2010CN1993353B Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
12/01/2010CN101903377A 6H-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists
12/01/2010CN101903373A Functionally selective alpha2c adrenoreceptor agonists
12/01/2010CN101903349A 4-(4-pyridinyl)-benzamides and their use as ROCK activity modulators
12/01/2010CN101903342A Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
12/01/2010CN101903340A Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/01/2010CN101903339A Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/01/2010CN101899050A Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
12/01/2010CN101899040A Preparation process of difenoconazole
12/01/2010CN101899039A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
12/01/2010CN101899011A Dithiocarbamates compound, preparation method and application thereof
11/2010
11/30/2010US7842825 Using 3-(3-chlorobiphenyl-4-oxymethyl)benzoic acid; antidiabetic agents; type 2 diabetes; insulin resistance; impaired glucose tolerance
11/30/2010US7842816 Mitogen-activated protein kinase kinase inhibitors such as 2-amino-3-methylbutyric acid 2-{[6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H -benzoimidazole-5-carbonyl]-aminooxy}-ethylester, used for the treatment of diseases, such as cancer and inflammation in mammals
11/30/2010US7842808 Anti-migraine spirocycles
11/30/2010US7842695 such as 1-{1-[5-(4-Fluorophenyl)pyridin-2-yl]-5-furan-2-yl-1H-pyrazol-4-ylmethyl}-4-methylpiperazine, exhibiting selective serotonin receptor antagonistic properties, used for the prophylaxis and/or treatment of psychoses, neurological disorders, amyotrophic lateral sclerosis, eating and vision disorders
11/30/2010US7842693 For therapy of rheumatoid arthritis, multiple sclerosis, transplant rejection, dermnatitis, eczema, urticaria, vasculitis, inflammatory bowel disease, food allergy and encephalomyelitis
11/30/2010CA2519938C Prostaglandin analogs as ep4 receptor agonists
11/30/2010CA2513440C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
11/30/2010CA2482858C Tricyclic thrombin receptor antagonists
11/30/2010CA2450076C Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or a diagnostic agent and pharmaceutical preparations containing said compounds
11/30/2010CA2440218C Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
11/30/2010CA2335477C Sulfonamide inhibitors of aspartyl protease
11/25/2010WO2010134052A1 Process for the preparation of olmesartan medoxomil
11/25/2010WO2010133973A1 1,4 dihydropyridine derivatives and their uses
11/25/2010WO2010133528A1 Heterocyclic antiviral compounds
11/25/2010WO2010099379A8 Jak kinase modulating quinazoline derivatives and methods of use thereof
11/25/2010WO2010081036A3 Fluorine containing compounds and methods of use thereof
11/25/2010US20100298558 Substituted dihydroazole compound and pest control agent
11/25/2010US20100298392 Isoindoline Derivatives For The Treatment Of Arrhythmias
11/25/2010US20100298346 Nitrogenous heterocyclic compounds with insecticidal activity, and the preparation and use thereof
11/25/2010US20100298345 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
11/25/2010US20100298323 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/25/2010US20100298270 Novel Compounds and Methods of Using Them
11/25/2010US20100298168 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/25/2010US20100297073 Heterocyclic antiviral compounds
11/25/2010CA2762846A1 Process for the preparation of olmesartan medoxomil
11/25/2010CA2762805A1 1,4-dihydropyridine derivatives and their uses
11/25/2010CA2761279A1 Heterocyclic antiviral compounds
11/24/2010EP2253620A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
11/24/2010EP2253614A1 Inhibitors of IAP
11/24/2010EP2253610A1 Method for manufacturing 4-aminobut-2-enolids
11/24/2010EP2252594A2 5-fluoro pyrimidine derivatives as fungicides
11/24/2010EP2252593A1 Substituted pyridazine derivatives which have histamine h3 antagonist activity
11/24/2010EP2252592A1 Arylchalcogeno-arylalkyl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof
11/24/2010EP2252586A1 Compounds and compositions as modulators of gpr119 activity
11/24/2010EP2252372A1 2-aminoquinolines
11/24/2010EP2252299A1 Fused pyridone m1 receptor positive allosteric modulators
11/24/2010EP1883451B1 Substituted indole compounds having nos inhibitory activity
11/24/2010EP1583972B1 Methods for identifying drug non-target proteins
11/24/2010EP1539739B1 Piperidinyl compounds that selectively bind integrins
11/24/2010EP1497287B1 Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer
11/24/2010CN1880304B Triamide-substituted indoles, benzofuranes and benzothiophenes
11/24/2010CN101896472A HEDGEHOG pathway antagonists and therapeutic applications thereof
11/24/2010CN101896461A Gamma secretase modulators
11/24/2010CN101891734A Complex for preparing plant bactericide
11/24/2010CN101891728A Scutellarein derivative as well as preparation method and application thereof
11/24/2010CN101891689A Preparation method of hydrochloric acid gamma-hydroxy bendamustine
11/24/2010CN101891680A Modulators of atp-binding cassette transporters
11/24/2010CN101306613B Color imaging method
11/23/2010US7838554 dyslipidemia; regulating lipid, lipoprotein, insulin, glucose levels in the blood; 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid; 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol; 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; 2,2,14,14-Tetramethyl-pentadecane-1,6,10,15-tetraol
11/23/2010US7838538 pyripyropene derivative; agricultural or horticultural insecticide;
11/23/2010US7838537 Viral polymerase inhibitors
11/23/2010US7838530 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
11/23/2010US7838527 Methods of treating cancer and related methods
11/23/2010US7838525 modulators of glucose metabolism, GPCR, RUP3; metabolic disorders and complications thereof such as diabetes and obesity; 4-[5-Cyano-6-(6-methylsulfanyl-pyridin-3-ylamino)-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid tert-butyl ester
11/23/2010US7838524 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
11/23/2010US7838518 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease
11/23/2010US7837981 Methods for imaging soluble A-beta
11/23/2010CA2599860C 1, 2, 4-triazole derivatives and their use as oxytocin antagonists
11/23/2010CA2496295C Novels pyrazole compounds as transforming growth factor (tgf) inhibitors
11/23/2010CA2487489C Mitotic kinesin inhibitors
11/23/2010CA2477892C Process for synthesizing chiral n-aryl piperazines
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/18/2010WO2010132852A2 Protease inhibitors
11/18/2010WO2010132601A1 Antiviral compounds
11/18/2010WO2010132524A1 2-azatriphenylene materials for organic light emitting diodes
11/18/2010WO2010132247A1 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010WO2010131738A1 Azetidine compound and medicinal use thereof
11/18/2010WO2010131691A1 Polyketide compound
1 ... 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 ... 694